EP3511323
2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.3.2014EP published:
2.3.2022EP application number:
18201850.7
EPO information:
European Patent Register
Max expiry date:
11.3.2034
Title in English:
2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORSLanguage of the patent:
English
Timeline
Today
12.3.2014EP application
2.3.2022EP Publication
Owner
Name:
GlaxoSmithKline Intellectual Property (No.2) LimitedAddress:
980 Great West Road Brentford, Middlesex, TW8 9GS, GB
Inventor
Name:
AMANS, DominiqueAddress:
Brentford, Middlesex TW8 9GS, GB
Name:
ATKINSON, Stephen JohnAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
HARRISON, Lee AndrewAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
HIRST, David JonathanAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
LAW, Robert PeterAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
LINDON, MatthewAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
PRESTON, AlexanderAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
SEAL, Jonathan ThomasAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
WELLAWAY, Christopher RolandAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Priority
Number:
201361781583 PDate:
14.3.2013Country:
US
Number:
201361882798 PDate:
26.9.2013Country:
US
Classification
Categories:
C07D 215/227, C07D 215/46, A61K 31/4706, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/04, C07D 405/14, C07D 409/14, C07D 413/04, C07D 413/12, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/08, C07D 498/04, A61P 29/00